| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | — | +83.6% |
| Cost of Revenue | $1.00B | — | +157.7% |
| Gross Profit | $406.0M | — | +7.4% |
| R&D Expense | $54.0M | — | +25.6% |
| SG&A Expense | $157.0M | — | +82.6% |
| Operating Income | $195.0M | — | -21.7% |
| Pre-tax Income | $132.0M | — | -43.3% |
| Income Tax | $20.0M | — | -51.2% |
| Net Income | $112.0M | — | -41.7% |
| EPS (Basic) | $1.35 | — | -40.3% |
| EPS (Diluted) | $1.33 | — | -40.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $311.0M | -79.2% | -58.7% |
| Accounts Receivable | $892.0M | +167.9% | +134.1% |
| Inventory | $835.0M | +164.2% | +139.3% |
| Current Assets | $2.30B | +3.1% | +47.1% |
| Total Assets | $8.70B | +43.1% | +62.2% |
| Current Liabilities | $1.25B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $156.0M | — | -13.8% |
| Capital Expenditures | $53.0M | — | +103.8% |
| Investing Cash Flow | -$2.62B | — | -9961.5% |
| Financing Cash Flow | $1.28B | — | +795.7% |
| Free Cash Flow | $103.0M | — | -33.5% |
| +143.1% |
| Long-term Debt | $4.25B | +46.0% | +76.0% |
| Total Liabilities | $6.80B | +61.3% | +83.7% |
| Stockholders' Equity | $1.90B | +1.9% | +14.3% |